NO973539D0 - Prolinderivater anvendelige som inhibitorer for human leukocyttelastase - Google Patents

Prolinderivater anvendelige som inhibitorer for human leukocyttelastase

Info

Publication number
NO973539D0
NO973539D0 NO973539A NO973539A NO973539D0 NO 973539 D0 NO973539 D0 NO 973539D0 NO 973539 A NO973539 A NO 973539A NO 973539 A NO973539 A NO 973539A NO 973539 D0 NO973539 D0 NO 973539D0
Authority
NO
Norway
Prior art keywords
inhibitors
human leukocyte
derivatives useful
leukocyte elastase
proline derivatives
Prior art date
Application number
NO973539A
Other languages
English (en)
Other versions
NO973539L (no
Inventor
Peter Robert Bernstein
Chris Allan Veale
Elwyn Peter Davies
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of NO973539D0 publication Critical patent/NO973539D0/no
Publication of NO973539L publication Critical patent/NO973539L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO973539A 1995-02-03 1997-08-01 Prolinderivater anvendelige som inhibitorer for human leukocyttelastase NO973539L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9502152.3A GB9502152D0 (en) 1995-02-03 1995-02-03 Proline derivatives
PCT/GB1996/000193 WO1996023812A1 (en) 1995-02-03 1996-01-30 Proline derivatives useful as inhibitors of human leukocyte elastase

Publications (2)

Publication Number Publication Date
NO973539D0 true NO973539D0 (no) 1997-08-01
NO973539L NO973539L (no) 1997-10-01

Family

ID=10769064

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973539A NO973539L (no) 1995-02-03 1997-08-01 Prolinderivater anvendelige som inhibitorer for human leukocyttelastase

Country Status (23)

Country Link
US (4) US5686628A (no)
EP (1) EP0808327A1 (no)
JP (1) JPH10513173A (no)
KR (1) KR19980701869A (no)
CN (1) CN1172486A (no)
AR (1) AR003922A1 (no)
AU (1) AU704704B2 (no)
BR (1) BR9607095A (no)
CA (1) CA2209675A1 (no)
CZ (1) CZ246697A3 (no)
FI (1) FI973211A (no)
GB (1) GB9502152D0 (no)
HR (1) HRP960008A2 (no)
HU (1) HUP9801991A3 (no)
IL (1) IL117013A0 (no)
NO (1) NO973539L (no)
NZ (1) NZ300256A (no)
PL (1) PL321680A1 (no)
RU (1) RU2159249C2 (no)
SK (1) SK105497A3 (no)
TR (1) TR199700732T1 (no)
WO (1) WO1996023812A1 (no)
ZA (1) ZA96851B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69733263T2 (de) 1996-09-16 2006-01-12 Ge Healthcare Ltd., Little Chalfont Markierte elastase-inhibitoren
US5773430A (en) * 1997-03-13 1998-06-30 Research Foundation Of State University Of New York Serine proteinase inhibitory activity by hydrophobic tetracycline
US6489300B1 (en) 1997-07-31 2002-12-03 Eugene D. Thorsett Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
US6559127B1 (en) 1997-07-31 2003-05-06 Athena Neurosciences, Inc. Compounds which inhibit leukocyte adhesion mediated by VLA-4
US6583139B1 (en) 1997-07-31 2003-06-24 Eugene D. Thorsett Compounds which inhibit leukocyte adhesion mediated by VLA-4
US6423688B1 (en) 1997-07-31 2002-07-23 Athena Neurosciences, Inc. Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4
US6362341B1 (en) 1997-07-31 2002-03-26 Athena Neurosciences, Inc. Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4
US7030114B1 (en) 1997-07-31 2006-04-18 Elan Pharmaceuticals, Inc. Compounds which inhibit leukocyte adhesion mediated by VLA-4
US6492421B1 (en) 1997-07-31 2002-12-10 Athena Neurosciences, Inc. Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
US7232918B2 (en) * 2001-11-06 2007-06-19 Shell Oil Company Catalyst composition
US6544732B1 (en) * 1999-05-20 2003-04-08 Illumina, Inc. Encoding and decoding of array sensors utilizing nanocrystals
AU2690100A (en) 1999-12-16 2001-06-25 Dainippon Pharmaceutical Co. Ltd. Processes for producing (aminomethyl)trifluorocarbinol derivatives
WO2006016720A1 (ja) * 2004-08-11 2006-02-16 Dainippon Sumitomo Pharma Co., Ltd. 医薬化合物
WO2006025216A1 (ja) * 2004-08-31 2006-03-09 Dainippon Sumitomo Pharma Co., Ltd. 医薬結晶化合物
GB2454122B (en) * 2005-02-08 2009-07-08 Smith International Thermally stable polycrystalline diamond cutting elements and bits incorporating the same
WO2018056373A1 (ja) * 2016-09-23 2018-03-29 科研製薬株式会社 （ｒ）‐５‐（３，４‐ジフルオロフェニル）‐５‐［（３‐メチル‐２‐オキソピリジン‐１（２ｈ）‐イル）メチル］イミダゾリジン‐２，４‐ジオンの製造方法およびその製造のための中間体
AU2020349353A1 (en) 2019-09-17 2022-04-14 Duke University Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
US20230218596A1 (en) 2020-04-16 2023-07-13 Mereo Biopharma 4 Limited Methods involving neutrophil elastase inhibitor alvelestat for treating coronavirus infection
WO2023067103A1 (en) 2021-10-20 2023-04-27 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4277395A (en) * 1980-06-16 1981-07-07 Richardson-Merrell Inc. Novel enzyme inhibitors
EP0124317B1 (en) * 1983-04-27 1990-04-11 Ici Americas Inc. Proline derivatives
US4518528A (en) * 1983-05-19 1985-05-21 Rasnick David W α Amino fluoro ketones
US5055450A (en) * 1985-01-22 1991-10-08 Ici Americas Inc. Peptide derivatives
US5194588A (en) * 1985-01-22 1993-03-16 Ici Americas Inc. Aminoalcohol intermediates for peptide derivatives
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
ZA86746B (en) * 1985-02-04 1986-09-24 Merrell Dow Pharma Novel peptidase inhibitors
CH672792A5 (no) * 1985-02-19 1989-12-29 Sandoz Ag
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives

Also Published As

Publication number Publication date
KR19980701869A (ko) 1998-06-25
US5808097A (en) 1998-09-15
CZ246697A3 (en) 1997-11-12
FI973211A0 (fi) 1997-08-01
WO1996023812A1 (en) 1996-08-08
US6054593A (en) 2000-04-25
BR9607095A (pt) 1997-11-11
NZ300256A (en) 2000-01-28
JPH10513173A (ja) 1998-12-15
TR199700732T1 (xx) 1998-02-21
MX9705231A (es) 1997-10-31
IL117013A0 (en) 1996-06-18
SK105497A3 (en) 1997-12-10
HRP960008A2 (en) 1998-04-30
FI973211A (fi) 1997-08-01
AU4494396A (en) 1996-08-21
US5686628A (en) 1997-11-11
CN1172486A (zh) 1998-02-04
AR003922A1 (es) 1998-09-30
AU704704B2 (en) 1999-04-29
ZA96851B (en) 1996-08-05
EP0808327A1 (en) 1997-11-26
HUP9801991A3 (en) 1999-06-28
GB9502152D0 (en) 1995-03-29
CA2209675A1 (en) 1996-08-08
US6048889A (en) 2000-04-11
PL321680A1 (en) 1997-12-22
RU2159249C2 (ru) 2000-11-20
HUP9801991A2 (hu) 1999-02-01
NO973539L (no) 1997-10-01

Similar Documents

Publication Publication Date Title
NO973539D0 (no) Prolinderivater anvendelige som inhibitorer for human leukocyttelastase
FI944804A (fi) Pyrimidinyyliasetamideja elastaasin estäjinä
NO980467L (no) 4-mercaptopyrrolidin-derivater som farnesyl-transerase-inhibitorer
BR9507179A (pt) Derivados de 3-aril-4-hidróxi-delta3-dihidrotiofena
BR9611130A (pt) Derivados de 3-aril-5-halógeno-pirona
DE69725465D1 (de) 6-phenylpyridyl-2-amin-derivate verwendbar als nos-inhibitoren
LV12102A (lv) Rotamazes funkciju inhibitori
DK0891362T3 (da) Pyrrolopyrrolon derivater som inhibitorer for neutrofil elastase
BR9605309A (pt) Composições de derivados piperazina
ITMI951020A0 (it) Derivati di diarildiammine
PT858464E (pt) Inibidores de trombina
PT927183E (pt) Inibidores espirociclicos de metaloproteases
EE200000138A (et) Pürrolopürrolooni derivaadid neutrofiili elastaasi inhibiitoritena
EE9700168A (et) Teraapias kasutatavad bitsüklilised isotiokarbamiidi derivaadid
DE69708629D1 (de) Alkyloxyamin-substituierte fluorenonderivate und ihre verwendung als proteinkinase-c-inhibitoren
EE200000137A (et) Pürrolopürrolooni derivaadid neutrofiili elastaasi inhibiitoritena
KR970702865A (ko) 신규 카르바페넴 유도체(Novel Carbapenem Derivatives)
PT863916E (pt) Tripeptidos de polifluoroalquil triptofano inibidores de trombina
BR9607046A (pt) Derivados de 3-pirrolidiliden-2-ona-cefalosporinas
IS4554A (is) Lyfjafræðileg notkun ákveðinna sýstín afleiða
DE69418656D1 (de) 2-acyloxycephemderivate als elastaseinhibitoren
FI960371A0 (fi) Tiatsolijohdannaisia lipoksigenaasi-inhibiittoreina
BR9704770A (pt) Derivados de 1-carba-(detia)-cefalosporina
SI0891362T1 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
NO945091D0 (no) Fluorholdige dipeptider som inhibitorer mot menneske-leukocyt-elastase-inhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application